{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:27:46Z","timestamp":1651220866571},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00292-020-00826-4","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T15:27:09Z","timestamp":1600356429000},"page":"621-633","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["S2k-Leitlinie Diagnostik und Therapie uteriner Sarkome \u2013 Anforderungen an die Pathologie"],"prefix":"10.1007","volume":"41","author":[{"given":"Lars-Christian","family":"Horn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Kathrin","family":"H\u00f6hn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Denschlag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"3","key":"826_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","volume":"54","author":"VM Abeler","year":"2009","unstructured":"Abeler\u00a0VM, R\u00f8yne\u00a0O, Thoresen\u00a0S, Danielsen\u00a0HE, Nesland\u00a0JM, Kristensen\u00a0GB (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a\u00a0total population from 1970 to 2000 including 419\u00a0patients. Histopathology 54(3):355\u2013364. https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03231.x","journal-title":"Histopathology"},{"issue":"5","key":"826_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/PGP.0b013e318249285b","volume":"31","author":"N Aggarwal","year":"2012","unstructured":"Aggarwal\u00a0N, Bhargava\u00a0R, Elishaev\u00a0E (2012) Uterine adenosarcomas. Diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis. Int J Gynecol Pathol 31(5):447\u2013452. https:\/\/doi.org\/10.1097\/PGP.0b013e318249285b","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"826_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/PGP.0000000000000451","volume":"37","author":"O Aisagbonhi","year":"2018","unstructured":"Aisagbonhi\u00a0O, Harrison\u00a0B, Zhao\u00a0L, Osgood\u00a0R, Chebib\u00a0I, Oliva\u00a0E (2018) YWHAE rearrangement in a\u00a0purely conventional low-grade endometrial stromal sarcoma that transformed over time to high-grade sarcoma. Importance of molecular testing. Int J Gynecol Pathol 37(5):441\u2013447. https:\/\/doi.org\/10.1097\/PGP.0000000000000451","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"826_CR4","first-page":"409","volume":"34","author":"SN Akers","year":"2013","unstructured":"Akers\u00a0SN, Groman\u00a0A, Odunsi\u00a0K, Lele\u00a0S, Frederick\u00a0PJ (2013) Adjuvant treatment for uterine leiomyosarcoma. Eur J Gynaecol Oncol 34(5):409\u2013414","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6","key":"826_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1309\/AJCPS88CMJRXZBWA","volume":"141","author":"J Albores-Saavedra","year":"2014","unstructured":"Albores-Saavedra\u00a0J, Dorantes-Heredia\u00a0R, Chabl\u00e9-Montero\u00a0F, Chanona-Vilchis\u00a0J, P\u00e9rez-Montiel\u00a0D, Leonardo Sa\u00fal\u00a0L\u2011S et al (2014) Endometrial stromal sarcomas. Immunoprofile with emphasis on HMB45 reactivity. Am J Clin Pathol 141(6):850\u2013855. https:\/\/doi.org\/10.1309\/AJCPS88CMJRXZBWA","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"826_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/jclinpath-2014-202829","volume":"68","author":"RH Ali","year":"2015","unstructured":"Ali\u00a0RH, Rouzbahman\u00a0M (2015) Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J\u00a0Clin Pathol 68(5):325\u2013332. https:\/\/doi.org\/10.1136\/jclinpath-2014-202829","journal-title":"J Clin Pathol"},{"issue":"3","key":"826_CR7","first-page":"2795","volume":"8","author":"M-ML Allen","year":"2015","unstructured":"Allen\u00a0M\u2011ML, Douds\u00a0JJ, Liang\u00a0SX, Desouki\u00a0MM, Parkash\u00a0V, Fadare\u00a0O (2015) An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas. Int J Clin Exp Pathol 8(3):2795\u20132801","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"826_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1048-891X.2004.14610.x","volume":"14","author":"F Amant","year":"2004","unstructured":"Amant\u00a0F, Steenkiste\u00a0E, Schurmans\u00a0K, Verbist\u00a0L, Abeler\u00a0VM, Tulunay\u00a0G et\u00a0al (2004) Immunohistochemical expression of CD10 antigen in uterine adenosarcoma. Int J Gynecol Cancer 14(6):1118\u20131121. https:\/\/doi.org\/10.1111\/j.1048-891X.2004.14610.x","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"826_CR9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ygyno.2004.03.021","volume":"93","author":"F Amant","year":"2004","unstructured":"Amant\u00a0F, Schurmans\u00a0K, Steenkiste\u00a0E, Verbist\u00a0L, Abeler\u00a0VM, Tulunay\u00a0G et\u00a0al (2004) Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma. Gynecol Oncol 93(3):680\u2013685. https:\/\/doi.org\/10.1016\/j.ygyno.2004.03.021","journal-title":"Gynecol Oncol"},{"issue":"9 Suppl 3","key":"826_CR10","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1097\/IGC.0000000000000205","volume":"24","author":"F Amant","year":"2014","unstructured":"Amant\u00a0F, Floquet\u00a0A, Friedlander\u00a0M, Kristensen\u00a0G, Mahner\u00a0S, Nam\u00a0EJ et\u00a0al (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma. Int J Gynecol Cancer 24(9 Suppl 3):S67\u2013S72. https:\/\/doi.org\/10.1097\/IGC.0000000000000205","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"826_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ygyno.2010.07.001","volume":"119","author":"R Arend","year":"2010","unstructured":"Arend\u00a0R, Bagaria\u00a0M, Lewin\u00a0SN, Sun\u00a0X, Deutsch\u00a0I, Burke\u00a0WM et al (2010) Long-term outcome and natural history of uterine adenosarcomas. Gynecol Oncol 119(2):305\u2013308. https:\/\/doi.org\/10.1016\/j.ygyno.2010.07.001","journal-title":"Gynecol Oncol"},{"issue":"1","key":"826_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/PAS.0b013e3181574d1e","volume":"32","author":"KA Atkins","year":"2008","unstructured":"Atkins\u00a0KA, Arronte\u00a0N, Darus\u00a0CJ, Rice\u00a0LW (2008) The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol 32(1):98\u2013102. https:\/\/doi.org\/10.1097\/PAS.0b013e3181574d1e","journal-title":"Am J Surg Pathol"},{"key":"826_CR13","unstructured":"AWMF (2018) S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom. Leitlinienprogramm Onkologie der Deutschen Krebsgesellschaft. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Endometriumkarzinom\/LL_Endometriumkarzinom_Langversion_1.0.pdf. Zugegriffen: 01.06.2020"},{"issue":"6","key":"826_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jmig.2010.07.001","volume":"17","author":"DC Badia","year":"2010","unstructured":"Badia\u00a0DC, Karini\u00a0H (2010) Endometrial stromal sarcoma diagnosed after uterine morcellation in laparoscopic supracervical hysterectomy. J\u00a0Minim Invasive Gynecol 17(6):791\u2013793. https:\/\/doi.org\/10.1016\/j.jmig.2010.07.001","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"826_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ygyno.2013.12.032","volume":"132","author":"H Bai","year":"2014","unstructured":"Bai\u00a0H, Yang\u00a0J, Cao\u00a0D, Huang\u00a0H, Xiang\u00a0Y, Wu\u00a0M et al (2014) Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma. A retrospective study of 153\u00a0cases. Gynecol Oncol 132(3):654\u2013660. https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.032","journal-title":"Gynecol Oncol"},{"issue":"1","key":"826_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ygyno.2011.10.010","volume":"125","author":"TL Beck","year":"2012","unstructured":"Beck\u00a0TL, Singhal\u00a0PK, Ehrenberg\u00a0HM, Rose\u00a0PG, Lele\u00a0SB, Krivak\u00a0TC, McBee\u00a0WC (2012) Endometrial stromal sarcoma. Analysis of recurrence following adjuvant treatment. Gynecol Oncol 125(1):141\u2013144. https:\/\/doi.org\/10.1016\/j.ygyno.2011.10.010","journal-title":"Gynecol Oncol"},{"issue":"6","key":"826_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","volume":"18","author":"SW Bell","year":"1994","unstructured":"Bell\u00a0SW, Kempson\u00a0RL, Hendrickson\u00a0MR (1994) Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213\u00a0cases. Am J Surg Pathol 18(6):535\u2013558","journal-title":"Am J Surg Pathol"},{"key":"826_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2147\/IJWH.S117754","volume-title":"International journal of women\u2019s health","author":"C Benson","year":"2017","unstructured":"Benson\u00a0C, Miah\u00a0AB (2017) Uterine sarcoma\u2014current perspectives. In: International journal of women\u2019s health, Bd. 9, S\u00a0597\u2013606. https:\/\/doi.org\/10.2147\/IJWH.S117754"},{"issue":"3","key":"826_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ygyno.2013.09.011","volume":"131","author":"B Bernard","year":"2013","unstructured":"Bernard\u00a0B, Clarke\u00a0BA, Malowany\u00a0JI, McAlpine\u00a0J, Cheng-Han\u00a0L, Atenafu\u00a0EG et al (2013) Uterine adenosarcomas: a\u00a0dual-institution update on staging, prognosis and survival. Gynecol Oncol 131(3):634\u2013639. https:\/\/doi.org\/10.1016\/j.ygyno.2013.09.011","journal-title":"Gynecol Oncol"},{"issue":"6","key":"826_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/jcp.2011.089664","volume":"64","author":"C Boyd","year":"2011","unstructured":"Boyd\u00a0C, McCluggage\u00a0WG (2011) Unusual morphological features of uterine leiomyomas treated with progestogens. J\u00a0Clin Pathol 64(6):485\u2013489. https:\/\/doi.org\/10.1136\/jcp.2011.089664","journal-title":"J Clin Pathol"},{"issue":"1","key":"826_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10397-015-0878-4","volume":"12","author":"H Br\u00f6lmann","year":"2015","unstructured":"Br\u00f6lmann\u00a0H, Tanos\u00a0V, Grimbizis\u00a0G, Ind\u00a0T, Philips\u00a0K, van den Bosch\u00a0T et\u00a0al (2015) Options on fibroid morcellation. A literature review. Gynecol Surg 12(1):3\u201315. https:\/\/doi.org\/10.1007\/s10397-015-0878-4","journal-title":"Gynecol Surg"},{"issue":"6","key":"826_CR22","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1365-2559.2011.04053.x","volume":"59","author":"DM Burch","year":"2011","unstructured":"Burch\u00a0DM, Tavassoli\u00a0FA (2011) Myxoid leiomyosarcoma of the uterus. Histopathology 59(6):1144\u20131155. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04053.x","journal-title":"Histopathology"},{"issue":"4","key":"826_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/PGP.0000000000000424","volume":"37","author":"A Busca","year":"2018","unstructured":"Busca\u00a0A, Gulavita\u00a0P, Parra-Herran\u00a0C, Islam\u00a0S (2018) IFITM1 outperforms CD10 in differentiating low-grade endometrial stromal sarcomas from smooth muscle neoplasms of the uterus. Int J Gynecol Pathol 37(4):372\u2013378. https:\/\/doi.org\/10.1097\/PGP.0000000000000424","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"826_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/ajo.12245","volume":"54","author":"TJ Cade","year":"2014","unstructured":"Cade\u00a0TJ, Quinn\u00a0MA, Rome\u00a0RM, Polyakov\u00a0A (2014) Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma. Aust N Z J Obstet Gynaecol 54(5):453\u2013456. https:\/\/doi.org\/10.1111\/ajo.12245","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8","key":"826_CR25","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","volume":"99","author":"JK Chan","year":"2008","unstructured":"Chan\u00a0JK, Kawar\u00a0NM, Shin\u00a0JY, Osann\u00a0K, Chen\u00a0L\u2011M, Powell\u00a0CB, Kapp\u00a0DS (2008) Endometrial stromal sarcoma. A population-based analysis. Br J Cancer 99(8):1210\u20131215. https:\/\/doi.org\/10.1038\/sj.bjc.6604527","journal-title":"Br J Cancer"},{"issue":"5","key":"826_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/00000478-199005000-00002","volume":"14","author":"KL Chang","year":"1990","unstructured":"Chang\u00a0KL, Crabtree\u00a0GS, Lim-Tan\u00a0SK, Kempson\u00a0RL, Hendrickson\u00a0MR (1990) Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117\u00a0cases. Am J Surg Pathol 14(5):415\u2013438. https:\/\/doi.org\/10.1097\/00000478-199005000-00002","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"826_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/PGP.0b013e31815ea7","volume":"27","author":"L Chen","year":"2008","unstructured":"Chen\u00a0L, Yang\u00a0B (2008) Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol 27(3):326\u2013332. https:\/\/doi.org\/10.1097\/PGP.0b013e31815ea7","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"826_CR28","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1365-2559.2011.04070.x","volume":"59","author":"E Chen","year":"2011","unstructured":"Chen\u00a0E, O\u2019Connell\u00a0F, Fletcher\u00a0CDM (2011) Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18\u00a0cases. Histopathology 59(6):1135\u20131143. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04070.x","journal-title":"Histopathology"},{"issue":"2","key":"826_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/PAP.0b013e3181cfb7c2","volume":"17","author":"I Chew","year":"2010","unstructured":"Chew\u00a0I, Oliva\u00a0E (2010) Endometrial stromal sarcomas. A review of potential prognostic factors. Adv Anat Pathol 17(2):113\u2013121. https:\/\/doi.org\/10.1097\/PAP.0b013e3181cfb7c2","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"826_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/his.12048","volume":"62","author":"S Chiang","year":"2013","unstructured":"Chiang\u00a0S, Oliva\u00a0E (2013) Recent developments in uterine mesenchymal neoplasms. Histopathology 62(1):124\u2013137. https:\/\/doi.org\/10.1111\/his.12048","journal-title":"Histopathology"},{"issue":"9","key":"826_CR31","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/PAS.0b013e3182262743","volume":"35","author":"S Chiang","year":"2011","unstructured":"Chiang\u00a0S, Ali\u00a0R, Melnyk\u00a0N, McAlpine\u00a0JN, Huntsman\u00a0DG, Gilks\u00a0CB et\u00a0al (2011) Frequency of known gene rearrangements in endometrial stromal tumors. Am J Surg Pathol 35(9):1364\u20131372. https:\/\/doi.org\/10.1097\/PAS.0b013e3182262743","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"826_CR32","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/modpathol.2017.42","volume":"30","author":"S Chiang","year":"2017","unstructured":"Chiang\u00a0S, Cheng-Han\u00a0L, Stewart\u00a0CJR, Oliva\u00a0E, Hoang\u00a0LN, Rola\u00a0AH et al (2017) BCOR is a\u00a0robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 30(9):1251\u20131261. https:\/\/doi.org\/10.1038\/modpathol.2017.42","journal-title":"Mod Pathol"},{"issue":"1","key":"826_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","volume":"9","author":"P Chudasama","year":"2018","unstructured":"Chudasama\u00a0P, Mughal\u00a0SS, Sanders\u00a0MA, H\u00fcbschmann\u00a0D, Chung\u00a0I, Deeg\u00a0KI et\u00a0al (2018) Integrative genomic and transcriptomic analysis of leiomyosarcoma. Nat Commun 9(1):144. https:\/\/doi.org\/10.1038\/s41467-017-02602-0","journal-title":"Nat Commun"},{"issue":"1","key":"826_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00004347-200001000-00006","volume":"19","author":"PB Clement","year":"2000","unstructured":"Clement\u00a0PB (2000) The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a\u00a0selective review with emphasis on recent advances. Int J Gynecol Pathol 19(1):39\u201355. https:\/\/doi.org\/10.1097\/00004347-200001000-00006","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"826_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0046-8177(90)90198-e.","volume":"21","author":"PB Clement","year":"1990","unstructured":"Clement\u00a0PB, Scully\u00a0RE (1990) Mullerian adenosarcoma of the uterus: a\u00a0clinicopathologic analysis of 100\u00a0cases with a\u00a0review of the literature. Hum Pathol 21(4):363\u2013381. https:\/\/doi.org\/10.1016\/0046-8177(90)90198-e","journal-title":"Hum Pathol"},{"issue":"12","key":"826_CR36","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.5858\/2005-129-1544-ICIGP","volume":"129","author":"D Coffey","year":"2005","unstructured":"Coffey\u00a0D, Kaplan\u00a0AL, Ramzy\u00a0I (2005) Intraoperative consultation in gynecologic pathology. Arch Pathol Lab Med 129(12):1544\u20131557","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"826_CR37","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.5858\/2006-130-1448-GOSTSR","volume":"130","author":"J-M Coindre","year":"2006","unstructured":"Coindre\u00a0J\u2011M (2006) Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 130(10):1448\u20131453","journal-title":"Arch Pathol Lab Med"},{"key":"826_CR38","volume-title":"Grading and staging of sarcoma. WHO classification of tumours of soft tissue and bone","author":"JM Coindre","year":"2013","unstructured":"Coindre\u00a0JM (2013) Grading and staging of sarcoma. WHO classification of tumours of soft tissue and bone, 4.\u00a0Aufl. International Agency for Research on Cancer (World Health Organization Classification of Tumours), Lyon (http:\/\/gbv.eblib.com\/patron\/FullRecord.aspx?p=4661026)","edition":"4"},{"issue":"6","key":"826_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/PAP.0000000000000046","volume":"21","author":"CMJ Conklin","year":"2014","unstructured":"Conklin\u00a0CMJ, Longacre\u00a0TA (2014) Endometrial stromal tumors. The new WHO classification. Adv Anat Pathol 21(6):383\u2013393. https:\/\/doi.org\/10.1097\/PAP.0000000000000046","journal-title":"Adv Anat Pathol"},{"issue":"10","key":"826_CR40","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.ejca.2007.04.008","volume":"43","author":"A Coosemans","year":"2007","unstructured":"Coosemans\u00a0A, Amini\u00a0NS, Caluwaerts\u00a0S, Lambin\u00a0S, Verbist\u00a0G, van Bree\u00a0R et\u00a0al (2007) Upregulation of Wilms\u2019 tumour gene 1 (WT1) in uterine sarcomas. Eur J Cancer 43(10):1630\u20131637. https:\/\/doi.org\/10.1016\/j.ejca\u00a0.2007.04.008","journal-title":"Eur J Cancer"},{"issue":"6","key":"826_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/PGP.0b013e31824fe289","volume":"31","author":"P Cossu-Rocca","year":"2012","unstructured":"Cossu-Rocca\u00a0P, Contini\u00a0M, Uras\u00a0MG, Muroni\u00a0MR, Pili\u00a0F, Carru\u00a0C et al (2012) Tyrosine kinase receptor status in endometrial stromal sarcoma. An immunohistochemical and genetic-molecular analysis. Int J Gynecol Pathol 31(6):570\u2013579. https:\/\/doi.org\/10.1097\/PGP.0b013e31824fe289","journal-title":"Int J Gynecol Pathol"},{"issue":"10","key":"826_CR42","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/modpathol.2013.69","volume":"26","author":"S Croce","year":"2013","unstructured":"Croce\u00a0S, Hostein\u00a0I, Ribeiro\u00a0A, Garbay\u00a0D, Velasco\u00a0V, Stoeckle\u00a0E et al (2013) YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations. Mod Pathol 26(10):1390\u20131400. https:\/\/doi.org\/10.1038\/modpathol.2013.69","journal-title":"Mod Pathol"},{"issue":"1","key":"826_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","volume":"116","author":"E D\u2019Angelo","year":"2010","unstructured":"D\u2019Angelo\u00a0E, Prat\u00a0J (2010) Uterine sarcomas. A review. Gynecol Oncol 116(1):131\u2013139. https:\/\/doi.org\/10.1016\/j.ygyno.2009.09.023","journal-title":"Gynecol Oncol"},{"issue":"2","key":"826_CR44","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ygyno.2011.01.022","volume":"121","author":"E D\u2019Angelo","year":"2011","unstructured":"D\u2019Angelo\u00a0E, Espinosa\u00a0I, Rola\u00a0A, Gilks\u00a0CB, van de Rijn\u00a0M, Cheng-Han\u00a0L, Prat\u00a0J (2011) Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl\u20112 identify two groups with different prognosis. Gynecol Oncol 121(2):328\u2013333. https:\/\/doi.org\/10.1016\/j.ygyno.2011.01.022","journal-title":"Gynecol Oncol"},{"issue":"4","key":"826_CR45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/PAS.0b013e318272c612","volume":"37","author":"E D\u2019Angelo","year":"2013","unstructured":"D\u2019Angelo\u00a0E, Rola\u00a0AH, Espinosa\u00a0I, Cheng-Han\u00a0L, Huntsman\u00a0DG, Gilks\u00a0B, Prat\u00a0J (2013) Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement. Am J Surg Pathol 37(4):514\u2013521. https:\/\/doi.org\/10.1097\/PAS.0b013e318272c612","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"826_CR46","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/his.12466","volume":"66","author":"EG Demicco","year":"2015","unstructured":"Demicco\u00a0EG, Boland\u00a0GM, Brewer\u00a0SKJ, Lusby\u00a0K, Young\u00a0ED, Ingram\u00a0D et\u00a0al (2015) Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value. Histopathology 66(5):627\u2013638. https:\/\/doi.org\/10.1111\/his.12466","journal-title":"Histopathology"},{"issue":"1","key":"826_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejso.2006.11.012","volume":"33","author":"D Denschlag","year":"2007","unstructured":"Denschlag\u00a0D, Masoud\u00a0I, Stanimir\u00a0G, Gilbert\u00a0L (2007) Prognostic factors and outcome in women with uterine sarcoma. Eur J Surg Oncol 33(1):91\u201395. https:\/\/doi.org\/10.1016\/j.ejso.2006.11.012","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"826_CR48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2559.2005.02288.x","volume":"48","author":"AT Deyrup","year":"2006","unstructured":"Deyrup\u00a0AT, Weiss\u00a0SW (2006) Grading of soft tissue sarcomas. The challenge of providing precise information in an imprecise world. Histopathology 48(1):42\u201350. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02288.x","journal-title":"Histopathology"},{"issue":"5","key":"826_CR49","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.7314\/apjcp.2012.13.5.1935","volume":"13","author":"A Durnali","year":"2012","unstructured":"Durnali\u00a0A, Tokluo\u011flu\u00a0S, \u00d6zdemir\u00a0N, Inan\u00e7\u00a0M, Alki\u015f\u00a0N, Zengin\u00a0N et\u00a0al (2012) Prognostic factors and treatment outcomes in 93\u00a0patients with uterine sarcoma from 4 centers in Turkey. Asian Pac J Cancer Prev 13(5):1935\u20131941. https:\/\/doi.org\/10.7314\/apjcp.2012.13.5.1935","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"826_CR50","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/j.humpath.2014.07.018","volume":"45","author":"S Ehdaivand","year":"2014","unstructured":"Ehdaivand\u00a0S, Simon\u00a0RA, Sung\u00a0CJ, Steinhoff\u00a0MM, Lawrence\u00a0WD, Quddus\u00a0MR (2014) Incidental gynecologic neoplasms in morcellated uterine specimens: a\u00a0case series with follow-up. Hum Pathol 45(11):2311\u20132317. https:\/\/doi.org\/10.1016\/j.humpath.2014.07.018","journal-title":"Hum Pathol"},{"issue":"5","key":"826_CR51","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1525-1438.2007.01126.x","volume":"18","author":"MH Einstein","year":"2008","unstructured":"Einstein\u00a0MH, Barakat\u00a0RR, Chi\u00a0DS, Sonoda\u00a0Y, Alektiar\u00a0KM, Hensley\u00a0ML, Abu-Rustum\u00a0NR (2008) Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. Int J Gynecol Cancer 18(5):1065\u20131070. https:\/\/doi.org\/10.1111\/j.1525-1438.2007.01126.x","journal-title":"Int J Gynecol Cancer"},{"key":"826_CR52","series-title":"World health organization classification of tumours, v.no. 4","volume-title":"Grading of breast cancer. WHO classification of tumours of the breast","author":"IO Ellis","year":"2012","unstructured":"Ellis\u00a0IO, Simpson\u00a0JF, Reis-Filho\u00a0JS, Decker\u00a0C (2012) Grading of breast cancer. WHO classification of tumours of the breast, 4.\u00a0Aufl. World health organization classification of tumours, v.no. 4. International Agency for Research on Cancer, Lyon (http:\/\/gbv.eblib.com\/patron\/FullRecord.aspx?p=4661025.)","edition":"4"},{"issue":"5","key":"826_CR53","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1365-2559.2011.04115.x","volume":"62","author":"W Feng","year":"2013","unstructured":"Feng\u00a0W, Hua\u00a0K, Gudlaugsson\u00a0E, Yu\u00a0Y, Zhou\u00a0X, Baak\u00a0JPA (2013) Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma. Histopathology 62(5):675\u2013687. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04115.x","journal-title":"Histopathology"},{"issue":"3","key":"826_CR54","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/IGC.0b013e318247aa14","volume":"23","author":"W Feng","year":"2013","unstructured":"Feng\u00a0W, Hua\u00a0K, Malpica\u00a0A, Zhou\u00a0X, Baak\u00a0JPA (2013) Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma. How much primary therapy is needed and how little is enough? Int J Gynecol Cancer 23(3):488\u2013493. https:\/\/doi.org\/10.1097\/IGC.0b013e318247aa14","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"826_CR55","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00428-018-2470-6","volume":"473","author":"J Ferreira","year":"2018","unstructured":"Ferreira\u00a0J, F\u00e9lix\u00a0A, Lennerz\u00a0JK, Oliva\u00a0E (2018) Recent advances in the histological and molecular classification of endometrial stromal neoplasms. Virchows Arch 473(6):665\u2013678. https:\/\/doi.org\/10.1007\/s00428-018-2470-6","journal-title":"Virchows Arch"},{"issue":"9 Suppl 3","key":"826_CR56","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/IGC.0000000000000239","volume":"24","author":"ML Friedlander","year":"2014","unstructured":"Friedlander\u00a0ML, Covens\u00a0A, Glasspool\u00a0RM, Hilpert\u00a0F, Kristensen\u00a0G, Kwon\u00a0S et\u00a0al (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract. Int J Gynecol Cancer 24(9 Suppl 3):78\u201382. https:\/\/doi.org\/10.1097\/IGC.0000000000000239","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"826_CR57","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/IGC.0b013e3181e9d0ba","volume":"20","author":"G Garg","year":"2010","unstructured":"Garg\u00a0G, Shah\u00a0JP, Liu\u00a0JR, Bryant\u00a0CS, Kumar\u00a0S, Munkarah\u00a0A, Morris\u00a0RT (2010) Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma. A population-based study. Int J Gynecol Cancer 20(7):1201\u20131206. https:\/\/doi.org\/10.1111\/IGC.0b013e3181e9d0ba","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"826_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygyno.2010.04.008","volume":"118","author":"G Garg","year":"2010","unstructured":"Garg\u00a0G, Shah\u00a0JP, Toy\u00a0EP, Bryant\u00a0CS, Kumar\u00a0S, Morris\u00a0RT (2010) Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol 118(1):8\u201313. https:\/\/doi.org\/10.1016\/j.ygyno.2010.04.008","journal-title":"Gynecol Oncol"},{"issue":"5","key":"826_CR59","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/IGC.0b013e3182916a1e","volume":"23","author":"RL Giuntoli","year":"2013","unstructured":"Giuntoli\u00a0RL, Lessard-Anderson\u00a0CR, Gerardi\u00a0MA, Kushnir\u00a0CL, Cliby\u00a0WA, Metzinger\u00a0DS, Gostout\u00a0BS (2013) Comparison of current staging systems and a\u00a0novel staging system for uterine leiomyosarcoma. Int J Gynecol Cancer 23(5):869\u2013876. https:\/\/doi.org\/10.1097\/IGC.0b013e3182916a1e","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"826_CR60","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/ijc.29141","volume":"136","author":"G Gremel","year":"2015","unstructured":"Gremel\u00a0G, Liew\u00a0M, Hamzei\u00a0F, Hardell\u00a0E, Selling\u00a0J, Ghaderi\u00a0M et al (2015) A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival. Int J Cancer 136(7):1608\u20131618. https:\/\/doi.org\/10.1002\/ijc.29141","journal-title":"Int J Cancer"},{"issue":"1","key":"826_CR61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1200\/JCO.1997.15.1.350","volume":"15","author":"L Guillou","year":"1997","unstructured":"Guillou\u00a0L, Coindre\u00a0JM, Bonichon\u00a0F, Nguyen\u00a0BB, Terrier\u00a0P, Collin\u00a0F et\u00a0al (1997) Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a\u00a0population of 410 adult patients with soft tissue sarcoma. J\u00a0Clin Oncol 15(1):350\u2013362. https:\/\/doi.org\/10.1200\/JCO.1997.15.1.350","journal-title":"J Clin Oncol"},{"issue":"15","key":"826_CR62","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1158\/1078-0432.CCR-14-3141","volume":"21","author":"X Guo","year":"2015","unstructured":"Guo\u00a0X, Jo\u00a0VY, Mills\u00a0AM, Zhu\u00a0SX, Cheng-Han\u00a0L, Espinosa\u00a0I et al (2015) Clinically relevant molecular subtypes in leiomyosarcoma. Clin Cancer Res 21(15):3501\u20133511. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-3141","journal-title":"Clin Cancer Res"},{"issue":"5","key":"826_CR63","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.3747\/co.20.1357","volume":"20","author":"AA Gupta","year":"2013","unstructured":"Gupta\u00a0AA, Yao\u00a0X, Verma\u00a0S, Mackay\u00a0H, Hopkins\u00a0L (2013) Chemotherapy (gemcitabine, docetaxel plus gemcitabine, doxorubicin, or trabectedin) in inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma. A clinical practice guideline. Curr Oncol 20(5):e448\u2013e454. https:\/\/doi.org\/10.3747\/co.20.1357","journal-title":"Curr Oncol"},{"issue":"2","key":"826_CR64","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ygyno.2005.01.002","volume":"97","author":"I Halbwedl","year":"2005","unstructured":"Halbwedl\u00a0I, Ullmann\u00a0R, Kremser\u00a0M\u2011L, Man\u00a0YG, Isadi-Moud\u00a0N, Lax\u00a0S et al (2005) Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization. Gynecol Oncol 97(2):582\u2013587. https:\/\/doi.org\/10.1016\/j.ygyno.2005.01.002","journal-title":"Gynecol Oncol"},{"issue":"9","key":"826_CR65","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/PAS.0000000000000894","volume":"41","author":"E Hardell","year":"2017","unstructured":"Hardell\u00a0E, Josefson\u00a0S, Ghaderi\u00a0M, Skeie-Jensen\u00a0T, Westbom-Fremer\u00a0S, Cheek\u00a0EH et al (2017) Validation of a\u00a0mitotic index cutoff as a\u00a0prognostic marker in undifferentiated uterine sarcomas. Am J Surg Pathol 41(9):1231\u20131237. https:\/\/doi.org\/10.1097\/PAS.0000000000000894","journal-title":"Am J Surg Pathol"},{"key":"826_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1365-2559.41.s2.33.x","volume":"41","author":"WR Hart","year":"2002","unstructured":"Hart\u00a0WR (2002) Symposium 2: mesenchymal lesions of the uterus. Histopathology 41:12\u201331","journal-title":"Histopathology"},{"issue":"3","key":"826_CR67","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ygyno.2017.03.021","volume":"145","author":"ML Hemming","year":"2017","unstructured":"Hemming\u00a0ML, Wagner\u00a0AJ, Nucci\u00a0MR, Chiang\u00a0S, Wang\u00a0L, Hensley\u00a0ML, George\u00a0S (2017) YWHAE-rearranged high-grade endometrial stromal sarcoma: two-center case series and response to chemotherapy. Gynecol Oncol 145(3):531\u2013535. https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.021","journal-title":"Gynecol Oncol"},{"key":"826_CR68","first-page":"233","volume-title":"Pathology and genetics of tumours of the breast and female genital organs. World Health Organization classification of tumours","author":"MA Hendrickson","year":"2003","unstructured":"Hendrickson\u00a0MA, Tavassoli\u00a0FA, Kempson\u00a0RL, McCluggage\u00a0WG, Haller\u00a0U, Kubik-Huch\u00a0RA (2003) Mesenchymal tumors and related lesions. In: Tavassoli\u00a0DPFA (Hrsg) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization classification of tumours. IARC Press, Lyon, S\u00a0233\u2013249"},{"issue":"8","key":"826_CR69","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/cncr.27942","volume":"119","author":"ML Hensley","year":"2013","unstructured":"Hensley\u00a0ML, Wathen\u00a0JK, Maki\u00a0RG, Araujo\u00a0DM, Sutton\u00a0G, Priebat\u00a0DA et al (2013) Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma. Results of a\u00a0phase 2 trial (SARC 005). Cancer 119(8):1555\u20131561. https:\/\/doi.org\/10.1002\/cncr.27942","journal-title":"Cancer"},{"issue":"2","key":"826_CR70","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.pathol.2017.11.086","volume":"50","author":"L Hoang","year":"2018","unstructured":"Hoang\u00a0L, Chiang\u00a0S, Cheng-Han\u00a0L (2018) Endometrial stromal sarcomas and related neoplasms. New developments and diagnostic considerations. Pathology 50(2):162\u2013177. https:\/\/doi.org\/10.1016\/j.pathol.2017.11.086","journal-title":"Pathology"},{"issue":"11","key":"826_CR71","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/PAS.0000000000000907","volume":"41","author":"A Hodgson","year":"2017","unstructured":"Hodgson\u00a0A, Amemiya\u00a0Y, Seth\u00a0A, Djordjevic\u00a0B, Parra-Herran\u00a0C (2017) High-grade M\u00fcllerian Adenosarcoma. Genomic and clinicopathologic characterization of a\u00a0distinct neoplasm with prevalent TP53 pathway alterations and aggressive behavior. Am J Surg Pathol 41(11):1513\u20131522. https:\/\/doi.org\/10.1097\/PAS.0000000000000907","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"826_CR72","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PAS.0000000000000303","volume":"39","author":"BE Howitt","year":"2015","unstructured":"Howitt\u00a0BE, Quade\u00a0BJ, Nucci\u00a0MR (2015) Uterine polyps with features overlapping with those of M\u00fcllerian adenosarcoma. A clinicopathologic analysis of 29\u00a0cases emphasizing their likely benign nature. Am J Surg Pathol 39(1):116\u2013126. https:\/\/doi.org\/10.1097\/PAS.0000000000000303","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"826_CR73","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jclinpath-2015-202915","volume":"68","author":"H Hwang","year":"2015","unstructured":"Hwang\u00a0H, Matsuo\u00a0K, Duncan\u00a0K, Pakzamir\u00a0E, Pham\u00a0HQ, Correa\u00a0A et\u00a0al (2015) Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new. J\u00a0Clin Pathol 68(9):710\u2013717. https:\/\/doi.org\/10.1136\/jclinpath-2015-202915","journal-title":"J Clin Pathol"},{"issue":"10","key":"826_CR74","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/cncr.27971","volume":"119","author":"A Iasonos","year":"2013","unstructured":"Iasonos\u00a0A, Keung\u00a0EZ, Zivanovic\u00a0O, Mancari\u00a0R, Peiretti\u00a0M, Nucci\u00a0M et\u00a0al (2013) External validation of a\u00a0prognostic nomogram for overall survival in women with uterine leiomyosarcoma. Cancer 119(10):1816\u20131822. https:\/\/doi.org\/10.1002\/cncr.27971","journal-title":"Cancer"},{"issue":"3","key":"826_CR75","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ygyno.2009.08.014","volume":"115","author":"YJ Ioffe","year":"2009","unstructured":"Ioffe\u00a0YJ, Li\u00a0AJ, Walsh\u00a0CS, Karlan\u00a0BY, Leuchter\u00a0R, Forscher\u00a0C, Cass\u00a0I (2009) Hormone receptor expression in uterine sarcomas. Prognostic and therapeutic roles. Gynecol Oncol 115(3):466\u2013471. https:\/\/doi.org\/10.1016\/j.ygyno.2009.08.014","journal-title":"Gynecol Oncol"},{"issue":"6","key":"826_CR76","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bpobgyn.2011.07.003","volume":"25","author":"PPC Ip","year":"2011","unstructured":"Ip\u00a0PPC, Cheung\u00a0ANY (2011) Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential. Best Pract Res Clin Obstet Gynaecol 25(6):691\u2013704. https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.07.003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"7","key":"826_CR77","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/PAS.0b013e3181a02d1c","volume":"33","author":"PPC Ip","year":"2009","unstructured":"Ip\u00a0PPC, Cheung\u00a0ANY, Clement\u00a0PB (2009) Uterine smooth muscle tumors of uncertain malignant potential (STUMP). A clinicopathologic analysis of 16\u00a0cases. Am J Surg Pathol 33(7):992\u20131005. https:\/\/doi.org\/10.1097\/PAS.0b013e3181a02d1c","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"826_CR78","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.23245","volume":"112","author":"DS Kapp","year":"2008","unstructured":"Kapp\u00a0DS, Shin\u00a0JY, Chan\u00a0JK (2008) Prognostic factors and survival in 1396\u00a0patients with uterine leiomyosarcomas. Emphasis on impact of lymphadenectomy and oophorectomy. Cancer 112(4):820\u2013830. https:\/\/doi.org\/10.1002\/cncr.23245","journal-title":"Cancer"},{"issue":"4","key":"826_CR79","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/mco.2013.124","volume":"1","author":"H Kobayashi","year":"2013","unstructured":"Kobayashi\u00a0H, Uekuri\u00a0C, Akasaka\u00a0J, Ito\u00a0F, Shigemitsu\u00a0A, Koike\u00a0N, Shigetomi\u00a0H (2013) The biology of uterine sarcomas. A review and update. mol clin onc 1(4):599\u2013609. https:\/\/doi.org\/10.3892\/mco.2013.124","journal-title":"mol clin onc"},{"issue":"1","key":"826_CR80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/gyno.2001.6334","volume":"83","author":"TC Krivak","year":"2001","unstructured":"Krivak\u00a0TC, Seidman\u00a0JD, McBroom\u00a0JW, MacKoul\u00a0PJ, Aye\u00a0LM, Rose\u00a0GS (2001) Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma. Comparison of treatment and survival. Gynecol Oncol 83(1):89\u201394. https:\/\/doi.org\/10.1006\/gyno.2001.6334","journal-title":"Gynecol Oncol"},{"issue":"8","key":"826_CR81","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/PAS.0b013e31816a3b42","volume":"32","author":"S Kurihara","year":"2008","unstructured":"Kurihara\u00a0S, Oda\u00a0Y, Ohishi\u00a0Y, Iwasa\u00a0A, Takahira\u00a0T, Kaneki\u00a0E et al (2008) Endometrial stromal sarcomas and related high-grade sarcomas. Immunohistochemical and molecular genetic study of 31\u00a0cases. Am J Surg Pathol 32(8):1228\u20131238. https:\/\/doi.org\/10.1097\/PAS.0b013e31816a3b42","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"826_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/modpathol.2009.162","volume":"23","author":"S Kurihara","year":"2010","unstructured":"Kurihara\u00a0S, Oda\u00a0Y, Ohishi\u00a0Y, Kaneki\u00a0E, Kobayashi\u00a0H, Wake\u00a0N, Tsuneyoshi\u00a0M (2010) Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas. Mod Pathol 23(2):225\u2013234. https:\/\/doi.org\/10.1038\/modpathol.2009.162","journal-title":"Mod Pathol"},{"issue":"3","key":"826_CR83","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/01.pgp.0000215291.22867.18","volume":"25","author":"MM Lam","year":"2006","unstructured":"Lam\u00a0MM, Corless\u00a0CL, Goldblum\u00a0JR, Heinrich\u00a0MC, Downs-Kelly\u00a0E, Rubin\u00a0BP (2006) Extragastrointestinal stromal tumors presenting as vulvovaginal\/rectovaginal septal masses. A diagnostic pitfall. Int J Gynecol Pathol 25(3):288\u2013292. https:\/\/doi.org\/10.1097\/01.pgp.0000215291.22867.18","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"826_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/his.12594","volume":"67","author":"C-H Lee","year":"2015","unstructured":"Lee\u00a0C\u2011H, Nucci\u00a0MR (2015) Endometrial stromal sarcoma--the new genetic paradigm. Histopathology 67(1):1\u201319. https:\/\/doi.org\/10.1111\/his.12594","journal-title":"Histopathology"},{"issue":"5","key":"826_CR85","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","volume":"36","author":"C-H Lee","year":"2012","unstructured":"Lee\u00a0C\u2011H, Mari\u00f1o-Enriquez\u00a0A, Ou\u00a0W, Zhu\u00a0M, Ali\u00a0RH, Chiang\u00a0S et al (2012) The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas. A histologically high-grade and clinically aggressive tumor. Am J Surg Pathol 36(5):641\u2013653. https:\/\/doi.org\/10.1097\/PAS.0b013e31824a7b1a","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"826_CR86","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/modpathol.2013.199","volume":"27","author":"C-H Lee","year":"2014","unstructured":"Lee\u00a0C\u2011H, Hoang\u00a0LN, Yip\u00a0S, Reyes\u00a0C, Marino-Enriquez\u00a0A, Eilers\u00a0G et al (2014) Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement. Mod Pathol 27(5):751\u2013757. https:\/\/doi.org\/10.1038\/modpathol.2013.199","journal-title":"Mod Pathol"},{"issue":"12","key":"826_CR87","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/modpathol.2009.122","volume":"22","author":"C-H Lee","year":"2009","unstructured":"Lee\u00a0C\u2011H, Turbin\u00a0DA, Sung\u00a0Y\u2011CV, Espinosa\u00a0I, Montgomery\u00a0K, van de Rijn\u00a0M, Gilks\u00a0CB (2009) A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors. Mod Pathol 22(12):1519\u20131531. https:\/\/doi.org\/10.1038\/modpathol.2009.122","journal-title":"Mod Pathol"},{"issue":"9","key":"826_CR88","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/modpathol.2016.99","volume":"29","author":"J-C Lee","year":"2016","unstructured":"Lee\u00a0J\u2011C, Tzu-Pin\u00a0L, Changou\u00a0CA, Liang\u00a0C\u2011W, Huang\u00a0H\u2011N, Lauria\u00a0A et al (2016) Genomewide copy number analysis of M\u00fcllerian adenosarcoma identified chromosomal instability in the aggressive subgroup. Mod Pathol 29(9):1070\u20131082. https:\/\/doi.org\/10.1038\/modpathol.2016.99","journal-title":"Mod Pathol"},{"issue":"1","key":"826_CR89","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ygyno.2005.09.055","volume":"101","author":"AL Leiser","year":"2006","unstructured":"Leiser\u00a0AL, Anderson\u00a0SE, Nonaka\u00a0D, Chuai\u00a0S, Olshen\u00a0AB, Chi\u00a0DS, Soslow\u00a0RA (2006) Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol 101(1):86\u201391. https:\/\/doi.org\/10.1016\/j.ygyno.2005.09.055","journal-title":"Gynecol Oncol"},{"issue":"6","key":"826_CR90","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/cncr.20521","volume":"101","author":"MM Leitao","year":"2004","unstructured":"Leitao\u00a0MM, Soslow\u00a0RA, Nonaka\u00a0D, Olshen\u00a0AB, Aghajanian\u00a0C, Sabbatini\u00a0P et\u00a0al (2004) Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101(6):1455\u20131462. https:\/\/doi.org\/10.1002\/cncr.20521","journal-title":"Cancer"},{"issue":"3","key":"826_CR91","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ygyno.2011.11.009","volume":"124","author":"MM Leitao","year":"2012","unstructured":"Leitao\u00a0MM, Hensley\u00a0ML, Barakat\u00a0RR, Aghajanian\u00a0C, Gardner\u00a0GJ, Jewell\u00a0EL et\u00a0al (2012) Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma. Gynecol Oncol 124(3):558\u2013562. https:\/\/doi.org\/10.1016\/j.ygyno.2011.11.009","journal-title":"Gynecol Oncol"},{"issue":"4","key":"826_CR92","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/modpathol.2017.162","volume":"31","author":"N Lewis","year":"2018","unstructured":"Lewis\u00a0N, Soslow\u00a0RA, Delair\u00a0DF, Park\u00a0KJ, Murali\u00a0R, Hollmann\u00a0TJ et al (2018) ZC3H7B-BCOR high-grade endometrial stromal sarcomas. A report of 17\u00a0cases of a\u00a0newly defined entity. Mod Pathol 31(4):674\u2013684. https:\/\/doi.org\/10.1038\/modpathol.2017.162","journal-title":"Mod Pathol"},{"issue":"5","key":"826_CR93","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/PAS.0b013e3182851162","volume":"37","author":"D Lim","year":"2013","unstructured":"Lim\u00a0D, Alvarez\u00a0T, Nucci\u00a0MR, Gilks\u00a0B, Longacre\u00a0T, Soslow\u00a0RA, Oliva\u00a0E (2013) Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma. Am J Surg Pathol 37(5):650\u2013658. https:\/\/doi.org\/10.1097\/PAS.0b013e3182851162","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"826_CR94","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1245\/s10434-012-2834-0","volume":"20","author":"K Lusby","year":"2013","unstructured":"Lusby\u00a0K, Brewer Savannah\u00a0K, Demicco\u00a0EG, Zhang\u00a0Y, Ghadimi\u00a0MP, Young\u00a0ED et\u00a0al (2013) Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers. A single institution\u2019s experience. Ann Surg Oncol 20(7):2364\u20132372. https:\/\/doi.org\/10.1245\/s10434-012-2834-0","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"826_CR95","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/PAS.0b013e3182893f36","volume":"37","author":"A Ly","year":"2013","unstructured":"Ly\u00a0A, Mills\u00a0AM, McKenney\u00a0JK, Balzer\u00a0BL, Kempson\u00a0RL, Hendrickson\u00a0MR, Longacre\u00a0TA (2013) Atypical leiomyomas of the uterus. A clinicopathologic study of 51\u00a0cases. Am J Surg Pathol 37(5):643\u2013649. https:\/\/doi.org\/10.1097\/PAS.0b013e3182893f36","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"826_CR96","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/PGP.0000000000000523","volume":"38","author":"S Mansor","year":"2019","unstructured":"Mansor\u00a0S, Kuick\u00a0CH, Lim\u00a0SL, Lei\u00a0S, Quek\u00a0R, Wong\u00a0APC, Lim-Tan\u00a0SK et al (2019) ZC3H7B-BCOR-rearranged endometrial stromal sarcomas. A distinct subset merits its own classification? Int J Gynecol Pathol 38(5):420\u2013425. https:\/\/doi.org\/10.1097\/PGP.0000000000000523","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"826_CR97","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/PAS.0000000000000993","volume":"42","author":"A Mari\u00f1o-Enriquez","year":"2018","unstructured":"Mari\u00f1o-Enriquez\u00a0A, Lauria\u00a0A, Przybyl\u00a0J, Ng\u00a0TL, Kowalewska\u00a0M, Debiec-Rychter\u00a0M et al (2018) BCOR internal tandem duplication in high-grade uterine sarcomas. Am J Surg Pathol 42(3):335\u2013341. https:\/\/doi.org\/10.1097\/PAS.0000000000000993","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"826_CR98","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/PAP.0b013e3181cfe732","volume":"17","author":"WG McCluggage","year":"2010","unstructured":"McCluggage\u00a0WG (2010) Mullerian adenosarcoma of the female genital tract. Adv Anat Pathol 17(2):122\u2013129. https:\/\/doi.org\/10.1097\/PAP.0b013e3181cfe732","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"826_CR99","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/PGP.0b013e31817a82","volume":"27","author":"WG McCluggage","year":"2008","unstructured":"McCluggage\u00a0WG, Young\u00a0RH (2008) Endometrial stromal sarcomas with true papillae and pseudopapillae. Int J Gynecol Pathol 27(4):555\u2013561. https:\/\/doi.org\/10.1097\/PGP.0b013e31817a82","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"826_CR100","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-2559.2009.03230.x","volume":"54","author":"WG McCluggage","year":"2009","unstructured":"McCluggage\u00a0WG, Ganesan\u00a0R, Herrington\u00a0CS (2009) Endometrial stromal sarcomas with extensive endometrioid glandular differentiation. Report of a\u00a0series with emphasis on the potential for misdiagnosis and discussion of the differential diagnosis. Histopathology 54(3):365\u2013373. https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03230.x","journal-title":"Histopathology"},{"key":"826_CR101","unstructured":"McCluggage WG, Fisher C, Hirschowitz L (2016) Dataset for histological reporting of uterine sarcomas. http:\/\/www.rcpath.org\/publications-media\/publications\/datasets\/uterine-sarcomas. Zugegriffen: 01.06.2020"},{"issue":"5","key":"826_CR102","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/PAS.0b013e318287779c","volume":"37","author":"AM Mills","year":"2013","unstructured":"Mills\u00a0AM, Ly\u00a0A, Balzer\u00a0BL, Hendrickson\u00a0MR, Kempson\u00a0RL, McKenney\u00a0JK, Longacre\u00a0TA (2013) Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma. Immunohistochemical study of 68\u00a0cases with clinical follow-up. Am J Surg Pathol 37(5):634\u2013642. https:\/\/doi.org\/10.1097\/PAS.0b013e318287779c","journal-title":"Am J Surg Pathol"},{"key":"826_CR103","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/OTT.S69507","volume":"8","author":"M Noventa","year":"2015","unstructured":"Noventa\u00a0M, Gizzo\u00a0S, Conte\u00a0L, Dalla Toffola\u00a0A, Litta\u00a0P, Saccardi\u00a0C (2015) Fertility sparing surgery in young women affected by endometrial stromal sarcoma. An oncologic dilemma or a\u00a0reliable option? review of literature starting from a\u00a0peculiar case. OTT 8:29\u201335. https:\/\/doi.org\/10.2147\/OTT.S69507","journal-title":"OTT"},{"issue":"4","key":"826_CR104","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00000478-200104000-00004","volume":"25","author":"MR Nucci","year":"2001","unstructured":"Nucci\u00a0MR, O\u2019Connell\u00a0JT, Huettner\u00a0PC, Cviko\u00a0A, Sun\u00a0D, Quade\u00a0BJ (2001) h\u2011Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 25(4):455\u2013463. https:\/\/doi.org\/10.1097\/00000478-200104000-00004","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"826_CR105","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/PGP.0000000000000141","volume":"33","author":"E Oliva","year":"2014","unstructured":"Oliva\u00a0E (2014) Cellular mesenchymal tumors of the uterus. A review emphasizing recent observations. Int J Gynecol Pathol 33(4):374\u2013384. https:\/\/doi.org\/10.1097\/PGP.0000000000000141","journal-title":"Int J Gynecol Pathol"},{"key":"826_CR106","first-page":"135","volume-title":"WHO classification of tumours of female reproductive tract","author":"E Oliva","year":"2014","unstructured":"Oliva\u00a0E, Carcangiu\u00a0ML, Carinelli\u00a0SG, Ip\u00a0P, Loening\u00a0T, Longacre\u00a0TA, Nucci\u00a0MR, Prat\u00a0J, Zaloudek\u00a0CJ (2014) Mesenchymal tumors of the uterus. In: Kurman\u00a0RJ, Carcangiu\u00a0ML, Herrington\u00a0CS, Young\u00a0RH (Hrsg) WHO classification of tumours of female reproductive tract. IARC Press, Lyon, S\u00a0135\u2013147"},{"issue":"4","key":"826_CR107","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","volume":"26","author":"E Oliva","year":"2002","unstructured":"Oliva\u00a0E, Young\u00a0RH, Mahul\u00a0AB, Clement\u00a0PB (2002) An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus. A study of 54\u00a0cases emphasizing the importance of using a\u00a0panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26(4):403\u2013412. https:\/\/doi.org\/10.1097\/00000478-200204000-00001","journal-title":"Am J Surg Pathol"},{"key":"826_CR108","unstructured":"Otis CN, Ocampo AC, Nucci MR, McCluggage WG (2013) Protocol for the examination of specimens from patients with sarcoma of the uterus. For the members of the cancer committee, college of American Pathologists. http:\/\/webapps.cap.org\/apps\/docs\/committees\/cancer\/cancer_protocols\/2013\/UterineSarcomaProtocol_3000.pdf. Zugegriffen: 01.06.2020"},{"issue":"5","key":"826_CR109","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1440-1827.2004.01629.x","volume":"54","author":"SS Paik","year":"2004","unstructured":"Paik\u00a0SS, Oh\u00a0Y\u2011H, Jang\u00a0KS, Han\u00a0HX, Xiu\u00a0H, Cho\u00a0SH (2004) Uterine leiomyoma with massive lymphoid infiltration. Case report and review of the literature. Pathol Int 54(5):343\u2013348. https:\/\/doi.org\/10.1111\/j.1440-1827.2004.01629.x","journal-title":"Pathol Int"},{"issue":"12","key":"826_CR110","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1245\/s10434-011-1751-y","volume":"18","author":"J-Y Park","year":"2011","unstructured":"Park\u00a0J\u2011Y, Dae-Yeon\u00a0K, Jong-Hyeok\u00a0K, Yong-Man\u00a0K, Young-Tak\u00a0K, Joo-Hyun\u00a0N (2011) The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus. Ann Surg Oncol 18(12):3453\u20133461. https:\/\/doi.org\/10.1245\/s10434-011-1751-y","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"826_CR111","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00432-008-0422-2","volume":"134","author":"J-Y Park","year":"2008","unstructured":"Park\u00a0J\u2011Y, Kim\u00a0D\u2011Y, Suh\u00a0D\u2011S, Kim\u00a0J\u2011H, Kim\u00a0Y\u2011M, Kim\u00a0Y\u2011T, Nam\u00a0J\u2011H (2008) Prognostic factors and treatment outcomes of patients with uterine sarcoma. Analysis of 127\u00a0patients at a\u00a0single institution, 1989\u20132007. J\u00a0Cancer Res Clin Oncol 134(12):1277\u20131287. https:\/\/doi.org\/10.1007\/s00432-008-0422-2","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"826_CR112","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/IGC.0b013e3182738361","volume":"23","author":"J-Y Park","year":"2013","unstructured":"Park\u00a0J\u2011Y, Kyu-Rae\u00a0K, Joo-Hyun\u00a0N (2013) Immunohistochemical analysis for therapeutic targets and prognostic markers in low-grade endometrial stromal sarcoma. Int J Gynecol Cancer 23(1):81\u201389. https:\/\/doi.org\/10.1097\/IGC.0b013e3182738361","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"826_CR113","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/modpathol.2013.123","volume":"27","author":"CE Parra-Herran","year":"2014","unstructured":"Parra-Herran\u00a0CE, Yuan\u00a0L, Nucci\u00a0MR, Quade\u00a0BJ (2014) Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics. The IFITM1 model. Mod Pathol 27(4):569\u2013579. https:\/\/doi.org\/10.1038\/modpathol.2013.123","journal-title":"Mod Pathol"},{"issue":"9 Suppl 3","key":"826_CR114","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/IGC.0000000000000281","volume":"24","author":"P Pautier","year":"2014","unstructured":"Pautier\u00a0P, Nam\u00a0EJ, Provencher\u00a0DM, Hamilton\u00a0AL, Mangili\u00a0G, Siddiqui\u00a0NA et al (2014) Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus. Int J Gynecol Cancer 24(9 Suppl 3):73\u201377. https:\/\/doi.org\/10.1097\/IGC.0000000000000281","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"826_CR115","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/0002-9378(89)90878-8","volume":"160","author":"G Peacock","year":"1989","unstructured":"Peacock\u00a0G, Archer\u00a0S (1989) Myxoid leiomyosarcoma of the uterus. Case report and review of the literature. Am J Obstet Gynecol 160(6):1515\u20131519. https:\/\/doi.org\/10.1016\/0002-9378(89)90878-8","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"826_CR116","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/IGC.0b013e3181a1bfbc","volume":"19","author":"M Pelmus","year":"2009","unstructured":"Pelmus\u00a0M, Penault-Llorca\u00a0F, Guillou\u00a0L, Collin\u00a0F, Bertrand\u00a0G, Trassard\u00a0M et al (2009) Prognostic factors in early-stage leiomyosarcoma of the uterus. Int J Gynecol Cancer 19(3):385\u2013390. https:\/\/doi.org\/10.1111\/IGC.0b013e3181a1bfbc","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"826_CR117","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/IGC.0b013e31819a1f8","volume":"19","author":"T Perri","year":"2009","unstructured":"Perri\u00a0T, Korach\u00a0J, Sadetzki\u00a0S, Oberman\u00a0B, Fridman\u00a0E, Ben-Baruch\u00a0G (2009) Uterine leiomyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer 19(2):257\u2013260. https:\/\/doi.org\/10.1111\/IGC.0b013e31819a1f8","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl 2","key":"826_CR118","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/j.ijgo.2015.06.006","volume":"131","author":"J Prat","year":"2015","unstructured":"Prat\u00a0J, Mbatani\u00a0N (2015) Uterine sarcomas. Int J Gynaecol Obstet 131(Suppl 2):S105\u2013S110. https:\/\/doi.org\/10.1016\/j.ijgo.2015.06.006","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"826_CR119","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00000478-199704000-00003","volume":"21","author":"RA Prayson","year":"1997","unstructured":"Prayson\u00a0RA, Goldblum\u00a0JR, Hart\u00a0WR (1997) Epithelioid smooth-muscle tumors of the uterus: a\u00a0clinicopathologic study of 18\u00a0patients. Am J Surg Pathol 21(4):383\u2013391. https:\/\/doi.org\/10.1097\/00000478-199704000-00003","journal-title":"Am J Surg Pathol"},{"key":"826_CR120","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/B978-0-443-07477-6.50023-8","volume-title":"Robboy\u2019s pathology of the female reproductive tract","author":"BA Quade","year":"2009","unstructured":"Quade\u00a0BA, Robboy\u00a0SJ (2009) Uterine smooth muscle tumors. In: Robboy\u00a0SJ, Prat\u00a0J (Hrsg) Robboy\u2019s pathology of the female reproductive tract. Churchill Livingstone, New York, S\u00a0457\u2013484"},{"issue":"6","key":"826_CR121","first-page":"2883","volume":"34","author":"P Quan","year":"2014","unstructured":"Quan\u00a0P, Moinfar\u00a0F, Kufferath\u00a0I, Absenger\u00a0M, Kueznik\u00a0T, Denk\u00a0H et\u00a0al (2014) Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K\/AKT\/mTOR signaling. AR 34(6):2883\u20132897","journal-title":"AR"},{"issue":"6","key":"826_CR122","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/IGC.0b013e31829590dc","volume":"23","author":"JA Rauh-Hain","year":"2013","unstructured":"Rauh-Hain\u00a0JA, Oduyebo\u00a0T, Diver\u00a0EJ, Guseh\u00a0SH, George\u00a0S, Muto\u00a0MG, del Carmen\u00a0MG (2013) Uterine leiomyosarcoma: an updated series. Int J Gynecol Cancer 23(6):1036\u20131043. https:\/\/doi.org\/10.1097\/IGC.0b013e31829590dc","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"826_CR123","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/jclinpath-2012-201150","volume":"66","author":"SP Sah","year":"2013","unstructured":"Sah\u00a0SP, McCluggage\u00a0WG (2013) DOG1 immunoreactivity in uterine leiomyosarcomas. J\u00a0Clin Pathol 66(1):40\u201343. https:\/\/doi.org\/10.1136\/jclinpath-2012-201150","journal-title":"J Clin Pathol"},{"issue":"5","key":"826_CR124","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1016\/j.ijrobp.2011.11.005","volume":"82","author":"U Schick","year":"2012","unstructured":"Schick\u00a0U, Bolukbasi\u00a0Y, Thariat\u00a0J, Abdah-Bortnyak\u00a0R, Kuten\u00a0A, Igdem\u00a0S et al (2012) Outcome and prognostic factors in endometrial stromal tumors: a\u00a0Rare Cancer Network study. Int J Radiat Oncol Biol Phys 82(5):e757\u2013e763. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.11.005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"826_CR125","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/PAS.0000000000000256","volume":"38","author":"AP Sciallis","year":"2014","unstructured":"Sciallis\u00a0AP, Bedroske\u00a0PP, Schoolmeester\u00a0JK, Sukov\u00a0WR, Keeney\u00a0GL, Hodge\u00a0JC, Bell\u00a0DA (2014) High-grade endometrial stromal sarcomas: a\u00a0clinicopathologic study of a\u00a0group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol 38(9):1161\u20131172. https:\/\/doi.org\/10.1097\/PAS.0000000000000256","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"826_CR126","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ygyno.2017.05.036","volume":"146","author":"B-LL Seagle","year":"2017","unstructured":"Seagle\u00a0B\u2011LL, Shilpi\u00a0A, Buchanan\u00a0S, Goodman\u00a0C, Shahabi\u00a0S (2017) Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Gynecol Oncol 146(2):254\u2013262. https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.036","journal-title":"Gynecol Oncol"},{"issue":"5","key":"826_CR127","doi-asserted-by":"publisher","first-page":"591.e1","DOI":"10.1016\/j.ajog.2015.03.006","volume":"212","author":"MT Siedhoff","year":"2015","unstructured":"Siedhoff\u00a0MT, Wheeler\u00a0SB, Rutstein\u00a0SE, Geller\u00a0EJ, Doll\u00a0KM, Wu\u00a0JM, Clarke-Pearson\u00a0DL (2015) Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a\u00a0decision analysis. Am J Obstet Gynecol 212(5):591.e1\u2013591.e8. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.006","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"826_CR128","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/PAS.0b013e318161d1be","volume":"32","author":"RA Soslow","year":"2008","unstructured":"Soslow\u00a0RA, Asya\u00a0A, Oliva\u00a0E (2008) Mullerian adenosarcomas: an immunophenotypic analysis of 35\u00a0cases. Am J Surg Pathol 32(7):1013\u20131021. https:\/\/doi.org\/10.1097\/PAS.0b013e318161d1be","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"826_CR129","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ygyno.2012.12.036","volume":"129","author":"EJ Tanner","year":"2013","unstructured":"Tanner\u00a0EJ, Toussaint\u00a0T, Leitao\u00a0MM, Hensley\u00a0ML, Soslow\u00a0RA, Gardner\u00a0GJ, Jewell\u00a0EL (2013) Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecol Oncol 129(1):140\u2013144. https:\/\/doi.org\/10.1016\/j.ygyno.2012.12.036","journal-title":"Gynecol Oncol"},{"key":"826_CR130","series-title":"World Health Organization Classification of Tumours","volume-title":"Pathology and genetics of tumours of the breast and female genital organs","year":"2003","unstructured":"Tavassoli\u00a0FA, Devilee\u00a0P (Hrsg) (2003) Pathology and genetics of tumours of the breast and female genital organs. World Health Organization Classification of Tumours. IARC Press, Lyon"},{"key":"826_CR131","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13569-015-0024-0","volume":"5","author":"E Thanopoulou","year":"2015","unstructured":"Thanopoulou\u00a0E, Aleksic\u00a0A, Thway\u00a0K, Khabra\u00a0K, Judson\u00a0I (2015) Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital. Clin Sarcoma Res 5:8. https:\/\/doi.org\/10.1186\/s13569-015-0024-0","journal-title":"Clin Sarcoma Res"},{"issue":"4","key":"826_CR132","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3802\/jgo.2014.25.4.306","volume":"25","author":"SH Tirumani","year":"2014","unstructured":"Tirumani\u00a0SH, Deaver\u00a0P, Shinagare\u00a0AB, Tirumani\u00a0H, Hornick\u00a0JL, George\u00a0S, Ramaiya\u00a0NH (2014) Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113\u00a0patients. J\u00a0Gynecol Oncol 25(4):306\u2013312. https:\/\/doi.org\/10.3802\/jgo.2014.25.4.306","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"826_CR133","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5858\/2008-132-595-SMTOTU","volume":"132","author":"G Toledo","year":"2008","unstructured":"Toledo\u00a0G, Oliva\u00a0E (2008) Smooth muscle tumors of the uterus: a\u00a0practical approach. Arch Pathol Lab Med 132(4):595\u2013605","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"826_CR134","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/0284186X.2012.689111","volume":"51","author":"CG Trop\u00e9","year":"2012","unstructured":"Trop\u00e9\u00a0CG, Abeler\u00a0VM, Kristensen\u00a0GB (2012) Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol 51(6):694\u2013705. https:\/\/doi.org\/10.3109\/0284186X.2012.689111","journal-title":"Acta Oncol"},{"issue":"2","key":"826_CR135","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0090-8258(03)00274-9","volume":"90","author":"L Wang","year":"2003","unstructured":"Wang\u00a0L, Felix\u00a0JC, Lee\u00a0JL, Tan\u00a0PY, Tourgeman\u00a0DE, O\u2019Meara\u00a0AT, Amezcua\u00a0CA (2003) The proto-oncogene c\u2011kit is expressed in leiomyosarcomas of the uterus. Gynecol Oncol 90(2):402\u2013406. https:\/\/doi.org\/10.1016\/S0090-8258(03)00274-9","journal-title":"Gynecol Oncol"},{"key":"826_CR136","first-page":"148","volume-title":"WHO classification of tumours of female reproductive tract","author":"M Wells","year":"2014","unstructured":"Wells\u00a0M, Oliva\u00a0E, Palacios\u00a0J, Prat\u00a0J (2014) Mixed epithelial and mesenchymal tumors of the uterus. In: Kurman\u00a0RJ, Carcangiu\u00a0ML, Herrington\u00a0CS, Young\u00a0RH (Hrsg) WHO classification of tumours of female reproductive tract. IARC Press, Lyon, S\u00a0148\u2013151"},{"issue":"3","key":"826_CR137","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ygyno.2005.01.053","volume":"97","author":"CBM Wingen","year":"2005","unstructured":"Wingen\u00a0CBM, Pauwels\u00a0PAA, Debiec-Rychter\u00a0M, van Gemert\u00a0WG, Vos\u00a0MC (2005) Uterine gastrointestinal stromal tumour (GIST). Gynecol Oncol 97(3):970\u2013972. https:\/\/doi.org\/10.1016\/j.ygyno.2005.01.053","journal-title":"Gynecol Oncol"},{"issue":"1","key":"826_CR138","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2003.06.001","volume":"91","author":"WE Winter","year":"2003","unstructured":"Winter\u00a0WE, Seidman\u00a0JD, Krivak\u00a0TC, Chauhan\u00a0S, Carlson\u00a0JW, Rose\u00a0GS, Birrer\u00a0MJ (2003) Clinicopathological analysis of c\u2011kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus. Gynecol Oncol 91(1):3\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2003.06.001","journal-title":"Gynecol Oncol"},{"issue":"5","key":"826_CR139","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/PGP.0b013e3182729131","volume":"32","author":"TI Wu","year":"2013","unstructured":"Wu\u00a0TI, Chou\u00a0H\u2011H, Yeh\u00a0C\u2011J, Hsueh\u00a0S, Yang\u00a0J\u2011E, Jao\u00a0M\u2011S et al (2013) Clinicopathologic parameters and immunohistochemical study of endometrial stromal sarcomas. Int J Gynecol Pathol 32(5):482\u2013492. https:\/\/doi.org\/10.1097\/PGP.0b013e3182729131","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"826_CR140","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ygyno.2013.10.029","volume":"132","author":"A Yoon","year":"2014","unstructured":"Yoon\u00a0A, Park\u00a0J\u2011Y, Park\u00a0J\u2011Y, Lee\u00a0Y\u2011Y, Kim\u00a0T\u2011J, Choi\u00a0CH et al (2014) Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a\u00a0multicenter review of 114\u00a0cases. Gynecol Oncol 132(1):70\u201375. https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.029","journal-title":"Gynecol Oncol"},{"issue":"1","key":"826_CR141","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00004347-199901000-00004","volume":"18","author":"YL Zhai","year":"1999","unstructured":"Zhai\u00a0YL, Kobayashi\u00a0Y, Mori\u00a0A, Orii\u00a0A, Nikaido\u00a0T, Konishi\u00a0I, Fujii\u00a0S (1999) Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 18(1):20\u201328. https:\/\/doi.org\/10.1097\/00004347-199901000-00004","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"826_CR142","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/cncr.26333","volume":"118","author":"O Zivanovic","year":"2012","unstructured":"Zivanovic\u00a0O, Jacks\u00a0LM, Iasonos\u00a0A, Leitao\u00a0MM, Soslow\u00a0RA, Veras\u00a0E et al (2012) A nomogram to predict postresection 5\u2011year overall survival for patients with uterine leiomyosarcoma. Cancer 118(3):660\u2013669. https:\/\/doi.org\/10.1002\/cncr.26333","journal-title":"Cancer"},{"issue":"7","key":"826_CR143","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/00000478-198210000-00001","volume":"6","author":"ME King","year":"1982","unstructured":"King\u00a0ME, Dickersin\u00a0GR, Scully\u00a0RE (1982) Myxoid leiomyosarcoma of the uterus. A report of six cases. Am J Surg Pathol 6(7):589\u2013598. https:\/\/doi.org\/10.1097\/00000478-198210000-00001","journal-title":"Am J Surg Pathol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-020-00826-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:14:23Z","timestamp":1631837663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-020-00826-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":143,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1007\/s00292-020-00826-4","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"17 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.-C.\u00a0Horn, A.K.\u00a0H\u00f6hn, D.\u00a0Denschlag, M.\u00a0Follmann und D.\u00a0Schmidt geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}